8-K Announcements
5Material company update
Mar 5, 2026·SEC
Material company update
Jan 12, 2026·SEC
Material company update
Nov 6, 2025·SEC
Omada Health(OMDA)Earnings, Financials & Key Ratios
OMDA•NASDAQ
$15.86
$918M mkt cap·Price updated May 6, 2026
AboutOmada Health is a U.S.-based virtual-care provider offering clinically validated programs for chronic conditions like cardiometabolic disease, musculoskeletal care, and behavioral health—delivered digitally between doctor visits.Show more
- Revenue$260M+53.2%
- EBITDA-$6M+83.3%
- Net Income-$13M+72.9%
- EPS (Diluted)-0.22+74.1%
- Gross Margin65.52%+8.1%
- EBITDA Margin-2.49%+89.1%
- Operating Margin-4.6%+82.1%
- Net Margin-4.91%+82.3%
- ROE-8.68%+84.9%
- ROIC-68.89%+66.0%
- Interest Coverage-4.72+51.2%
OMDA Key Insights
Omada Health (OMDA) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
No significant strengths identified
✗Weaknesses
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
OMDA Price & Volume
Omada Health (OMDA) stock price & volume — 10-year historical chart
Loading chart...
OMDA Growth Metrics
Omada Health (OMDA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years42.89%
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-
Return on Capital
10 Years-31.41%
5 Years-31.41%
3 Years-29.01%
Last Year-7.33%
OMDA Recent Earnings
Omada Health (OMDA) EPS & revenue vs analyst estimates — last 3 quarters
●Beat EPS 3/3 qtrs (100%)●Beat Revenue 2/3 qtrs (67%)
Q2 2026Latest
Mar 5, 2026EPS
$0.13
Est $0.03
+333.3%
Revenue
$76M
Est $70M
+8.0%
Q4 2025
Nov 6, 2025EPS
$0.02
Est $0.10
+120.0%
Revenue
$68M
Est $69M
-1.5%
Q3 2025
Aug 7, 2025EPS
$0.09
Est $0.10
+10.0%
Revenue
$61M
Est $55M
+10.7%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Mar 5, 2026 | $0.13vs $0.03+333.3% | $76Mvs $70M+8.0% |
| Q4 2025 | Nov 6, 2025 | $0.02vs $0.10+120.0% | $68Mvs $69M-1.5% |
| Q3 2025 | Aug 7, 2025 | $0.09vs $0.10+10.0% | $61Mvs $55M+10.7% |
Based on last 3 quarters of dataView full earnings history →
OMDA Peer Comparison
Omada Health (OMDA) competitors in Virtual Care and Digital Programs — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 HIMS | 6.94B | 26.88 | 52.71 | 59% | 5.47% | 23.73% | 2.07 | |
 NVCR | 1.88B | 16.50 | -13.52 | 8.28% | -25.66% | -50.82% | 0.85 | |
 TDOC | 1.23B | 6.80 | -5.96 | -1.54% | -6.81% | -12.37% | 0.75 | |
 OPRX | 120.61M | 6.47 | 23.96 | 18.78% | 4.69% | 4.22% | 0.04 | |
 GDRX | 880.73M | 2.57 | 30.13 | 0.57% | 3.74% | 4.75% | 0.10 | |
 PHVS | 1.96B | 30.11 | -10.35 | -53.18% | 0.00 | |||
 DOCS | 5.17B | 25.69 | 23.14 | 19.98% | 37.54% | 24.45% | 0.01 | |
 AMWL | 119.11M | 7.15 | -1.20 | -1.98% | -48.16% | -33.48% | 0.02 |
Compare OMDA vs Peers
Omada Health (OMDA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
OMDA Income Statement
Omada Health (OMDA) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|
| Sales/Revenue | 89.19M | 122.78M | 169.8M | 260.21M |
| Revenue Growth % | - | 37.67% | 38.29% | 53.24% |
| Cost of Goods Sold | 46.39M | 52.81M | 66.92M | 89.71M |
| COGS % of Revenue | 52.02% | 43.01% | 39.41% | 34.48% |
| Gross Profit | 42.79M▲ 0% | 69.97M▲ 63.5% | 102.88M▲ 47.0% | 170.5M▲ 65.7% |
| Gross Margin % | 47.98% | 56.99% | 60.59% | 65.52% |
| Gross Profit Growth % | - | 63.52% | 47.03% | 65.73% |
| Operating Expenses | 115.14M | 135.97M | 146.53M | 182.47M |
| OpEx % of Revenue | 129.1% | 110.74% | 86.3% | 70.12% |
| Selling, General & Admin | 88.97M | 102.23M | 110.61M | 141.88M |
| SG&A % of Revenue | 99.76% | 83.26% | 65.14% | 54.52% |
| Research & Development | 26.17M | 33.74M | 35.92M | 40.59M |
| R&D % of Revenue | 29.34% | 27.48% | 21.16% | 15.6% |
| Other Operating Expenses | 0 | 0 | 0 | 0 |
| Operating Income | -72.35M▲ 0% | -66M▲ 8.8% | -43.65M▲ 33.9% | -11.97M▲ 72.6% |
| Operating Margin % | -81.12% | -53.75% | -25.71% | -4.6% |
| Operating Income Growth % | - | 8.78% | 33.85% | 72.57% |
| EBITDA | -68.02M | -61.55M | -38.85M | -6.48M |
| EBITDA Margin % | -76.27% | -50.13% | -22.88% | -2.49% |
| EBITDA Growth % | - | 9.51% | 36.88% | 83.32% |
| D&A (Non-Cash Add-back) | 4.33M | 4.45M | 4.8M | 5.49M |
| EBIT | -68.32M | -62.81M | -42.63M | -11.97M |
| Net Interest Income | -2M | 1.07M | -3.7M | 2.77M |
| Interest Income | 2.2M | 5.78M | 805K | 5.3M |
| Interest Expense | 4.2M | 4.71M | 4.51M | 2.53M |
| Other Income/Expense | -168K | -1.51M | -3.48M | -805K |
| Pretax Income | -72.52M▲ 0% | -67.51M▲ 6.9% | -47.14M▲ 30.2% | -12.78M▲ 72.9% |
| Pretax Margin % | -81.31% | -54.98% | -27.76% | -4.91% |
| Income Tax | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% |
| Net Income | -72.52M▲ 0% | -67.51M▲ 6.9% | -47.14M▲ 30.2% | -12.78M▲ 72.9% |
| Net Margin % | -81.31% | -54.98% | -27.76% | -4.91% |
| Net Income Growth % | - | 6.9% | 30.18% | 72.89% |
| Net Income (Continuing) | -72.52M | -67.51M | -47.14M | -12.78M |
| Discontinued Operations | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.30▲ 0% | -1.21▲ 6.9% | -0.85▲ 29.8% | -0.22▲ 74.1% |
| EPS Growth % | - | 6.92% | 29.75% | 74.12% |
| EPS (Basic) | -1.30 | -1.21 | -0.85 | -0.22 |
| Diluted Shares Outstanding | 55.74M | 55.74M | 55.74M | 58.43M |
| Basic Shares Outstanding | 55.74M | 55.74M | 55.74M | 58.43M |
| Dividend Payout Ratio | - | - | - | - |
OMDA Balance Sheet
Omada Health (OMDA) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|
| Total Current Assets | 188.56M | 142.88M | 113.06M | 272.93M |
| Cash & Short-Term Investments | 168.12M | 115.64M | 76.39M | 222.04M |
| Cash Only | 168.12M | 115.64M | 76.39M | 222.04M |
| Short-Term Investments | 0 | 0 | 0 | 0 |
| Accounts Receivable | 11.67M | 16.44M | 23.92M | 34.59M |
| Days Sales Outstanding | 47.75 | 48.87 | 51.42 | 48.51 |
| Inventory | 3.54M | 3.61M | 3.3M | 4.49M |
| Days Inventory Outstanding | 27.85 | 24.98 | 17.98 | 18.25 |
| Other Current Assets | 2.26M | 3.91M | 5.16M | 11.83M |
| Total Non-Current Assets | 33.24M | 32.2M | 37.83M | 32.47M |
| Property, Plant & Equipment | 6.06M | 5.6M | 6.07M | 7.94M |
| Fixed Asset Turnover | 14.71x | 21.93x | 27.96x | 32.76x |
| Goodwill | 13.24M | 13.24M | 13.24M | 13.24M |
| Intangible Assets | 8.31M | 6.27M | 4.26M | 2.41M |
| Long-Term Investments | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 5.63M | 7.09M | 14.26M | 8.88M |
| Total Assets | 221.8M▲ 0% | 175.08M▼ 21.1% | 150.89M▼ 13.8% | 305.41M▲ 102.4% |
| Asset Turnover | 0.40x | 0.70x | 1.13x | 0.85x |
| Asset Growth % | - | -21.06% | -13.82% | 102.4% |
| Total Current Liabilities | 34.51M | 43.79M | 53.95M | 75.73M |
| Accounts Payable | 4.11M | 3.62M | 4.17M | 10.28M |
| Days Payables Outstanding | 32.31 | 25.03 | 22.73 | 41.81 |
| Short-Term Debt | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 13.44M | 14.88M | 19.53M | 25.06M |
| Other Current Liabilities | 9.99M | 15.49M | 21.12M | 40.39M |
| Current Ratio | 5.46x | 3.26x | 2.10x | 3.60x |
| Quick Ratio | 5.36x | 3.18x | 2.03x | 3.54x |
| Cash Conversion Cycle | 43.29 | 48.82 | 46.66 | 24.96 |
| Total Non-Current Liabilities | 31.68M | 32.37M | 32.31M | 0 |
| Long-Term Debt | 28.89M | 29.38M | 29.77M | 0 |
| Capital Lease Obligations | 1.27M | 411K | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.52M | 2.58M | 2.54M | 0 |
| Total Liabilities | 66.19M | 76.16M | 86.26M | 75.73M |
| Total Debt | 30.81M | 30.58M | 30.19M | 0 |
| Net Debt | -137.31M | -85.06M | -46.21M | -222.04M |
| Debt / Equity | 0.20x | 0.31x | 0.47x | - |
| Debt / EBITDA | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - |
| Interest Coverage | -17.22x | -14.03x | -9.69x | -4.72x |
| Total Equity | 155.6M▲ 0% | 98.92M▼ 36.4% | 64.63M▼ 34.7% | 229.68M▲ 255.4% |
| Equity Growth % | - | -36.43% | -34.66% | 255.37% |
| Book Value per Share | 2.79 | 1.77 | 1.16 | 3.93 |
| Total Shareholders' Equity | 155.6M | 98.92M | 64.63M | 229.68M |
| Common Stock | 21K | 7K | 8K | 58K |
| Retained Earnings | -329.32M | -396.83M | -443.97M | -456.74M |
| Treasury Stock | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 |
OMDA Cash Flow Statement
Omada Health (OMDA) cash flow — operating, investing & free cash flow history
| Line item | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|
| Cash from Operations | -68.98M | -49.74M | -34.18M | 18.25M |
| Operating CF Margin % | -77.34% | -40.51% | -20.13% | 7.01% |
| Operating CF Growth % | - | 27.89% | 31.28% | 153.4% |
| Net Income | -72.52M | -67.51M | -47.14M | -12.78M |
| Depreciation & Amortization | 4.33M | 4.45M | 4.8M | 5.49M |
| Stock-Based Compensation | 6.65M | 8.74M | 9.42M | 12.96M |
| Deferred Taxes | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.7M | 6.08M | 5.3M | 8.85M |
| Working Capital Changes | -9.14M | -1.5M | -6.57M | 3.74M |
| Change in Receivables | -3.93M | -5.34M | -8.8M | -12.36M |
| Change in Inventory | -1.95M | -74K | 318K | -1.19M |
| Change in Payables | -4.99M | -286K | 399K | 6.29M |
| Cash from Investing | -2.72M | -2.92M | -3.86M | -5.83M |
| Capital Expenditures | -720K | -416K | -596K | -1.32M |
| CapEx % of Revenue | 0.81% | 0.34% | 0.35% | 0.51% |
| Acquisitions | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - |
| Other Investing | -2M | -2.5M | -3.27M | -4.51M |
| Cash from Financing | 16.32M | 179K | -1.21M | 133.22M |
| Debt Issued (Net) | -1.27M | 963K | 0 | -30.96M |
| Equity Issued (Net) | 1000K | 1000K | 1000K | 1000K |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 |
| Other Financing | 1.27M | -2.54M | -4.54M | -5.71M |
| Net Change in Cash | -55.38M▲ 0% | -52.48M▲ 5.2% | -39.25M▲ 25.2% | 145.64M▲ 471.1% |
| Free Cash Flow | -71.7M▲ 0% | -52.66M▲ 26.6% | -38.04M▲ 27.8% | 16.93M▲ 144.5% |
| FCF Margin % | -80.4% | -42.89% | -22.4% | 6.51% |
| FCF Growth % | - | 26.56% | 27.76% | 144.5% |
| FCF per Share | -1.29 | -0.94 | -0.68 | 0.29 |
| FCF Conversion (FCF/Net Income) | 0.95x | 0.74x | 0.73x | -1.43x |
| Interest Paid | 3.61M | 4.09M | 3.85M | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 |
OMDA Key Ratios
Omada Health (OMDA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Return on Equity (ROE) | -46.6% | -53.05% | -57.64% | -8.68% |
| Return on Invested Capital (ROIC) | - | -307.92% | -202.83% | -68.89% |
| Gross Margin | 47.98% | 56.99% | 60.59% | 65.52% |
| Net Margin | -81.31% | -54.98% | -27.76% | -4.91% |
| Debt / Equity | 0.20x | 0.31x | 0.47x | - |
| Interest Coverage | -17.22x | -14.03x | -9.69x | -4.72x |
| FCF Conversion | 0.95x | 0.74x | 0.73x | -1.43x |
| Revenue Growth | - | 37.67% | 38.29% | 53.24% |
OMDA SEC Filings & Documents
Omada Health (OMDA) SEC filings — annual & quarterly reports (10-K, 10-Q)
OMDA Frequently Asked Questions
Omada Health (OMDA) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Omada Health (OMDA) reported $260.2M in revenue for fiscal year 2025. This represents a 192% increase from $89.2M in 2022.
Omada Health (OMDA) grew revenue by 53.2% over the past year. This is strong growth.
Omada Health (OMDA) reported a net loss of $12.8M for fiscal year 2025.
Dividend & Returns
Omada Health (OMDA) has a return on equity (ROE) of -8.7%. Negative ROE indicates the company is unprofitable.
Omada Health (OMDA) generated $16.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More OMDA
Omada Health (OMDA) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates